Raise closed, search for fresh raises on Seedstage

New York, NY

Developing an AI-enabled, low-cost, needle-free CGM solution to improve diabetes management.

• Mission: Transforming the continuous glucose monitoring (CGM) landscape with a low-cost, needle-free solution to improve diabetes management and health outcomes.  
• Innovation: AI-enabled, micro-needle sensing platform designed to provide accurate, reliable, and painless glucose monitoring for individuals with diabetes, pre-diabetes, and obesity.  
• Health Impact: Aims to make CGM accessible to over one billion individuals, enhancing their ability to monitor glucose levels and manage health conditions more effectively.  
• Sustainability: Focuses on reducing medical waste and single-use plastics by integrating reusable battery pods and daily disposable sensors into the system.  
• Clinical Validation: Supported by over a decade of R&D and extensive clinical data, demonstrating the potential for precision health monitoring.  
• Market Opportunity: Addresses the growing global need for affordable, effective diabetes management solutions.  

One Health Biosensing is focused on transforming the continuous glucose monitoring (CGM) landscape through the development of an innovative, AI-enabled health sensing platform. This platform aims to provide a low-cost, painless, and needle-free CGM solution that addresses the needs of over one billion individuals living with diabetes, pre-diabetes, and obesity.

With over a decade of research and development behind its proprietary silicon micro-needle array technology, the company holds more than 50 patents to protect its advancements. One Health has already demonstrated impressive performance through extensive clinical data, showcasing its potential to deliver accurate and reliable glucose monitoring.

The fundraising initiative seeks to support the further development and commercialization of this groundbreaking technology, ultimately aiming to improve health outcomes for a significant portion of the population while making CGM accessible to a wider audience.

By redefining CGM, One Health Biosensing aspires to contribute positively to the management of diabetes and related health conditions, offering a solution that aligns with the growing demand for effective health monitoring tools.

Company Info

Make Sense Of Your Health offers an innovative continuous glucose monitoring device aimed at improving accessibility for people with type 2 diabetes.

Make Sense Of Your Health is focused on providing a next-generation intradermal continuous glucose monitoring (CGM) device designed to improve accessibility and affordability for individuals with type 2 diabetes (T2D). The device, which has been developed over a decade, features a micro-needle sensing platform that eliminates the need for traditional needles. The system is built to minimize costs through the integration of a reusable battery pod and daily disposable sensors, allowing for a customizable user experience. The goal is to enhance health outcomes by offering AI-enabled precision guidance and a pain-free, flexible monitoring solution that caters to the diverse needs of users. The company is committed to sustainability by reducing single-use plastics and medical waste. Despite the promise of the technology, it is important to note that the continuous health sensor is currently investigational and has not received FDA approval, limiting its availability and established performance characteristics.